Fatal agranulocytosis associated with Metamizole treatment in a 16-year-old girl
Open Access
- 2 October 2019
- journal article
- Published by Heighten Science Publications Corporation in Archives of Case Reports
- Vol. 3 (1), 035-037
- https://doi.org/10.29328/journal.acr.1001019
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Métamizole: bénéfices et risques par rapport au paracétamol et aux AINSForum Médical Suisse ‒ Swiss Medical Forum, 2017
- «Absence of evidence is not evidence of absence» …Forum Médical Suisse ‒ Swiss Medical Forum, 2017
- Use of metamizole in children and the risk of agranulocytosisEuropean Journal of Anaesthesiology, 2015
- Metamizole for postoperative pain therapy in 1177 childrenEuropean Journal of Anaesthesiology, 2015
- Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance StudyEuropean Journal of Clinical Pharmacology, 2014
- Dipyrone‐Induced Granulocytopenia: A Case for AwarenessPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- Agranulocytoses aiguës médicamenteuses. Étude clinique à propos de 30 patients et évolution des étiologies sur 2 décenniesLa Revue de Médecine Interne, 1995
- Immune‐mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodiesBritish Journal of Haematology, 1989
- AGRANULOCYTIC LEUKOPENIA INDUCED BY A DRUG RELATED TO AMINOPYRINEJournal of the American Medical Association, 1936